Bloomberg Markets and Finance
02 Aug 2026, 12:00 UTC · 2h ago
Inside J&J's Lab to Create a Simpler Robotic Surgery Device
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Bloomberg Markets and Finance
02 Aug 2026, 12:00 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
1 claim · each scored for market impact
Johnson & Johnson has received FDA approval for its new surgical robot, Ottava. — FDA approval is a critical regulatory milestone that allows the company to begin commercializing a high-value medical product.
+0.60Which stocks this story touches
The company received FDA approval for its new surgical robot, Ottava, after significant investment.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Continue reading
6 related stories
Search tags
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
The Motley Fool
4h ago
